An investigation of the constancy of effect in Cochrane systematic reviews in context with the assumptions for noninferiority trials
Abstract When designing a noninferiority (NI) study one of the most important steps is to set the noninferiority (NI) limit. The NI limit is an acceptable loss of efficacy for a new investigative treatment compared to an active control treatment – often standard care. The limit should be a value so...
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
BMC
2022-07-01
|
| Σειρά: | BMC Medical Research Methodology |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s12874-022-01684-9 |